Zenotech Labs Gets U.S. FDA Approval for Ondansetron Injection

Zenotech Laboratories Ltd. (ZTL), an Indian drugmaker, received approval from the U.S. Food and Drug Administration for its ondansetron injection, a copy of Glaxosmithkline Plc. (GSK)’s Zofran anti-nausea medicine, according to a statement on the regulator’s website.

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Pradeep Kurup at pkurup3@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.